28391978|t|Recombinant protein transduction domain - Cu/Zn superoxide dismutase alleviates bone cancer pain via peroxiredoxin 4 modulation and antioxidation
28391978|a|Bone cancer pain (BCP) is a serious chronic clinical condition and reactive oxygen species (ROS) were considered to be involved in its development and persistency. Normally, superoxide dismutase (SOD) converts superoxide anions to hydrogen peroxide (H2O2) and H2O2 is then naturalized to be water by peroxiredoxin 4. We reported previously that recombinant protein transduction domain (PTD)- Cu/Zn SOD effectively scavenged excessive ROS and prevented cardiomyocytes from hypoxia-reoxygenation damage. However, whether PTD - Cu/Zn SOD would prevent BCP development is unknown. In the current study, we found that an implanted carcinoma in the rat tibia induced remarkable hyperalgesia, increased H2O2 levels and decreased SOD and peroxiredoxin 4 levels. After administration of recombinant PTD - Cu/Zn SOD to these tumor-burden rats, their hyperalgesia was significantly attenuated and peroxiredoxin 4 expression was significantly increased. In addition, an increased expression of N-methyl-d-aspartic acid (NMDA) receptors and a decreased expression of γ-aminobutyric acid (GABA) receptors in this cancer pain were prevented by PTD - Cu/Zn SOD administration or peroxiredoxin 4 overexpression. Our data suggested that reactive oxygen species, at least in part, play a role in cancer metastatic pain development and persistency which can be attenuated by the adminstration of recombinant PTD - Cu/Zn SOD via the peroxiredoxin 4 modulation from oxidative stress.
28391978	0	11	Recombinant	T103	UMLS:C0034861
28391978	12	39	protein transduction domain	T082	UMLS:C1514562
28391978	42	68	Cu/Zn superoxide dismutase	T103	UMLS:C0010461
28391978	80	91	bone cancer	T038	UMLS:C0279530
28391978	92	96	pain	T033	UMLS:C0596240
28391978	101	116	peroxiredoxin 4	T103	UMLS:C0914290
28391978	117	127	modulation	T038	UMLS:C1148560
28391978	132	145	antioxidation	T038	UMLS:C1148560
28391978	146	157	Bone cancer	T038	UMLS:C0279530
28391978	158	162	pain	T033	UMLS:C0596240
28391978	164	167	BCP	T033	UMLS:C0596240
28391978	213	236	reactive oxygen species	T103	UMLS:C0162772
28391978	238	241	ROS	T103	UMLS:C0162772
28391978	320	340	superoxide dismutase	T103	UMLS:C0038838
28391978	342	345	SOD	T103	UMLS:C0038838
28391978	356	373	superoxide anions	T103	UMLS:C0038836
28391978	377	394	hydrogen peroxide	T103	UMLS:C0020281
28391978	396	400	H2O2	T103	UMLS:C0020281
28391978	406	410	H2O2	T103	UMLS:C0020281
28391978	437	442	water	T103	UMLS:C0043047
28391978	446	461	peroxiredoxin 4	T103	UMLS:C0914290
28391978	466	474	reported	T170	UMLS:C0684224
28391978	491	502	recombinant	T103	UMLS:C0034861
28391978	503	530	protein transduction domain	T082	UMLS:C1514562
28391978	532	535	PTD	T082	UMLS:C1514562
28391978	538	547	Cu/Zn SOD	T103	UMLS:C0010461
28391978	560	569	scavenged	T038	UMLS:C1148560
28391978	580	583	ROS	T103	UMLS:C0162772
28391978	598	612	cardiomyocytes	T017	UMLS:C0225828
28391978	665	668	PTD	T082	UMLS:C1514562
28391978	671	680	Cu/Zn SOD	T103	UMLS:C0010461
28391978	695	698	BCP	T033	UMLS:C0596240
28391978	738	743	study	T062	UMLS:C0681814
28391978	748	753	found	T033	UMLS:C0150312
28391978	762	771	implanted	T074	UMLS:C0021102
28391978	772	781	carcinoma	T038	UMLS:C0007097
28391978	789	792	rat	T204	UMLS:C0034721
28391978	793	798	tibia	T017	UMLS:C0040184
28391978	818	830	hyperalgesia	T033	UMLS:C0020429
28391978	842	846	H2O2	T103	UMLS:C0020281
28391978	868	871	SOD	T103	UMLS:C0038838
28391978	876	891	peroxiredoxin 4	T103	UMLS:C0914290
28391978	924	935	recombinant	T103	UMLS:C0034861
28391978	936	939	PTD	T082	UMLS:C1514562
28391978	942	951	Cu/Zn SOD	T103	UMLS:C0010461
28391978	974	978	rats	T204	UMLS:C0034721
28391978	986	998	hyperalgesia	T033	UMLS:C0020429
28391978	1032	1047	peroxiredoxin 4	T103	UMLS:C0914290
28391978	1048	1058	expression	T038	UMLS:C1171362
28391978	1128	1169	N-methyl-d-aspartic acid (NMDA) receptors	T103	UMLS:C0080093
28391978	1200	1236	γ-aminobutyric acid (GABA) receptors	T103	UMLS:C0206518
28391978	1245	1256	cancer pain	T033	UMLS:C0596240
28391978	1275	1278	PTD	T082	UMLS:C1514562
28391978	1281	1290	Cu/Zn SOD	T103	UMLS:C0010461
28391978	1309	1324	peroxiredoxin 4	T103	UMLS:C0914290
28391978	1325	1339	overexpression	T038	UMLS:C1514559
28391978	1365	1388	reactive oxygen species	T103	UMLS:C0162772
28391978	1423	1440	cancer metastatic	T038	UMLS:C0027627
28391978	1441	1445	pain	T033	UMLS:C0596240
28391978	1522	1537	recombinant PTD	T103	UMLS:C0034861
28391978	1540	1549	Cu/Zn SOD	T103	UMLS:C0010461
28391978	1558	1573	peroxiredoxin 4	T103	UMLS:C0914290
28391978	1574	1584	modulation	T038	UMLS:C1148560
28391978	1590	1606	oxidative stress	T038	UMLS:C0242606